<DOC>
	<DOCNO>NCT00943371</DOCNO>
	<brief_summary>A single dose study assess safety , tolerability , pharmacokinetics pharmacokinetics MK6349 Type 2 Diabetics .</brief_summary>
	<brief_title>A Single-Dose Study MK6349 Patients With Type 2 Diabetes ( 6349-002 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Subject nonsmoking male female ( female must postmenopausal , tubal ligation hysterectomy ) 18 55 year age Subject Type 2 Diabetes currently treat diet exercise alone less 3 oral diabetes drug Subject insulin PPAR agonist medication Subject Type 1 diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>